Literature DB >> 12360169

Coronary vascular dysfunction in premenopausal women with diabetes mellitus.

Marcelo F Di Carli1, Luis Afonso, Roxana Campisi, Preeti Ramappa, Daniela Bianco-Batlles, George Grunberger, Heinrich R Schelbert.   

Abstract

BACKGROUND: Diabetes mellitus abolishes the sex differential in coronary artery disease morbidity and mortality in premenopausal women. This finding is independent of other diabetes-associated risk factors, suggesting that other mechanisms such as impaired coronary vascular function may contribute to the increased cardiovascular risk in women with diabetes. The objective of this study was to investigate the effect of diabetes on coronary vascular function in premenopausal women.
METHODS: We studied 13 premenopausal women with diabetes (aged 41 +/- 10 years) who were free of overt cardiovascular complications, and 21 control women (12 age-matched and 9 postmenopausal [aged 56 +/- 8 years]). We used [13N]-ammonia as the flow tracer and positron emission testing to measure myocardial blood flow (MBF) at rest, during maximal hyperemia, and in response to cold pressor testing.
RESULTS: Baseline MBF was lower in the postmenopausal controls, reflecting the differences in cardiac work and oxygen demand as assessed by the rate-pressure product. However, baseline MBFs were similar in the 3 groups after normalization for differences in the rate-pressure product. During hyperemia, MBF increased and coronary vascular resistance decreased significantly in the 3 groups. However, the increase (from baseline) in MBF in the women with diabetes (164% +/- 58%) was less than in the premenopausal controls (258% +/- 81%, P =.021), but not significantly different from the postmenopausal control women (204% +/- 104%, P =.51). Likewise, the increase in MBF in response to cold pressor testing in the women with diabetes (24% +/- 19%) was significantly lower than in the premenopausal controls (60% +/- 39%, P =.013), but similar to that in postmenopausal control women (27% +/- 15%, P =.97). These differences persisted after adjusting for age and diabetes-associated metabolic abnormalities.
CONCLUSIONS: These results demonstrate reduced coronary vasodilator function and impaired response of resistance vessels to increased sympathetic stimulation in premenopausal women with diabetes, similar to those observed in healthy postmenopausal women in whom the sex differential in coronary artery disease morbidity and mortality is no longer present.

Entities:  

Mesh:

Year:  2002        PMID: 12360169

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Assessment of coronary flow reserve and microcirculation: a clinical perspective.

Authors:  Roxana Campisi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

2.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

3.  Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.

Authors:  Aditya Goel; Yingmin Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Cardiovasc Res       Date:  2007-07-04       Impact factor: 10.787

4.  Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients.

Authors:  Mario Petretta; Wanda Acampa; Stefania Daniele; Maria Piera Petretta; Carmela Nappi; Roberta Assante; Emilia Zampella; Pierluigi Costanzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2012-10-23       Impact factor: 5.952

Review 5.  Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomography.

Authors:  Roxana Campisi; Fernando D Marengo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

6.  Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging.

Authors:  Louise Emmett; William J Van Gaal; Michael Magee; Sarah Bass; Onn Ali; S Ben Freedman; Hans Van der Wall; Leonard Kritharides
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

7.  Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs.

Authors:  Rui Zhang; Der Thor; Xiaoyuan Han; Leigh Anderson; Roshanak Rahimian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

8.  Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status.

Authors:  Manouchehr Nakhjavani; Mehrnaz Imani; Mehrdad Larry; Arash Aghajani-Nargesi; Afsaneh Morteza; Alireza Esteghamati
Journal:  J Diabetes Metab Disord       Date:  2014-11-23

9.  Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography.

Authors:  Henrik Engblom; Hui Xue; Shahnaz Akil; Marcus Carlsson; Cecilia Hindorf; Jenny Oddstig; Fredrik Hedeer; Michael S Hansen; Anthony H Aletras; Peter Kellman; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-19       Impact factor: 5.364

Review 10.  Quantitative cardiac positron emission tomography: the time is coming!

Authors:  Roberto Sciagrà
Journal:  Scientifica (Cairo)       Date:  2012-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.